Related Experiment Video
Updated: Dec 26, 2025

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Microbiota-mediated mucosal inflammation in arthritis
Meagan E Chriswell1, Kristine A Kuhn1
1Division of Rheumatology, University of Colorado School of Medicine, 1775 Aurora Ct. Mail Stop B115, Aurora, CO 80045, USA.
Microbial communities at mucosal surfaces influence the immune system. Disruptions in this microbial balance are linked to arthritis development through various mechanisms, highlighting the importance of microbe-host interactions.
Area of Science:
- Microbiology
- Immunology
- Rheumatology
Background:
- Mucosal surfaces host a diverse microbial ecology in symbiosis with the host.
- Microbes possess significant immunomodulatory potential, influencing host immune responses.
- The mucosal immune system maintains a balance between tolerance and inflammation.
Purpose of the Study:
- To review current knowledge on microbe-host interactions in arthritis development.
- To explore mechanisms linking microbial dysbiosis to arthritis.
Main Methods:
- Literature review of studies on microbial translocation, metabolite production, immune education, and molecular mimicry.
- Synthesis of current understanding of microbe-host interactions in the context of arthritis.
Main Results:
- Microbial dysbiosis at mucosal surfaces is implicated in various human diseases, including arthritis.
- Mechanisms include bacterial translocation, production of bacterial metabolites, immune response modulation, and molecular mimicry.
- The full implications of these disruptions are still under investigation.
Conclusions:
- Microbe-host interactions play a critical role in the pathogenesis of arthritis.
- Understanding these interactions is crucial for developing novel therapeutic strategies for arthritis.
More Related Videos
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

